OneThree Biotech

OneThree Biotech is a biotechnology company based in New York, founded in 2018.

The company utilizes a biology-driven artificial intelligence platform to enhance drug discovery and development for the pharmaceutical and biotech sectors. Their mission is to combine biology with AI to uncover new biological insights and improve the success rate of bringing therapeutics to market. The core product is an AI-driven discovery platform that integrates various biological, chemical, and clinical data to identify new drugs in a matter of weeks. Key capabilities include target discovery, compound identification, toxicity prediction, biomarker selection, and predicting mechanisms of action. OneThree Biotech has developed drugs for conditions such as ovarian cancer, solid tumors, and kidney cancer. They also offer free toxicity screening for small molecules aimed at treating COVID-19 for academic and medical researchers. The company collaborates with major industry players like AstraZeneca and has a strong focus on serving the biotech and pharmaceutical industries.